Medicine and Dentistry
Prostate Cancer
100%
Magnetic Resonance Imaging
52%
Malignant Neoplasm
39%
Neoplasm
28%
Adipose Tissue
24%
Cancer
24%
Diseases
23%
Computer Assisted Tomography
21%
Sex Difference
21%
Visceral Fat
21%
Metastatic Carcinoma
20%
Positron Emission Tomography
19%
Metabolism
17%
Multiparametric Magnetic Resonance Imaging
16%
Biopsy Technique
15%
Overall Survival
15%
Polyethylene Terephthalate
15%
Metabolomics
14%
Cancer Cell
14%
Gamma-Aminobutyric Acid
14%
Ganglioglioma
14%
Body Mass Index
13%
Biological Marker
13%
Recurrent Disease
12%
Clear Cell Renal Cell Carcinoma
12%
Transgenic Mouse
12%
Glioblastoma
10%
Cancer Metabolism
10%
Glycan
10%
Oral Cancer
9%
Lipogenesis
9%
Uterine Cancer
9%
Proteomics
9%
Prostate Specific Antigen
7%
Prostatectomy
7%
Matrix-Assisted Laser Desorption-Ionization
7%
Magnetic Resonance Imaging of Prostate
7%
Risk Stratification
7%
Metabolite
7%
Localized Disease
7%
Radioactive Tracer
7%
Gene Linkage
7%
Obesity
6%
Tumor Metabolism
6%
In Vitro
6%
Cell Metabolism
6%
Subcutaneous Fat
6%
Glucose Metabolism
6%
Solid Malignant Neoplasm
6%
Neuroendocrine Differentiation
6%
Keyphrases
Prostate Cancer
72%
Multiparametric MRI (mpMRI)
45%
Sex Differences
27%
Tumor
26%
Metabolic Pathway
23%
Neuroendocrine Cancer
23%
Prostate
22%
Visceral Fat
20%
Metabolism
19%
NCCN Guidelines
19%
Glycolysis
17%
Clinically Significant Prostate Cancer
17%
Magnetic Resonance Imaging
16%
Poor Prognosis
15%
Positron Emission Tomography
15%
Renal Cell Carcinoma
14%
Body Composition
13%
Cancer Genome Atlas
13%
Obesity
13%
Overall Survival
13%
Computed Tomography
13%
In Cancer
11%
Glioma
11%
Neuroendocrine Cells
11%
Cancer Metabolism
10%
PH-sensitive
10%
Extracellular pH
10%
Subcutaneous Adipose Tissue
9%
Visceral Adipose Tissue
9%
Recurrent Disease
9%
Bitter Melon Extract
9%
Oral Cancer
9%
Lipogenesis
9%
Theranostic Platform
9%
Spatial Proteomics
9%
Sex-specific
9%
Calcium Carbonate Nanoparticles
9%
Cocaine
9%
Acetylcholine Receptor (AChR)
9%
Nicotinic Acetylcholine Receptor (nAChR)
9%
Body Composition Analysis
9%
Neuroendocrine Phenotype
9%
Metastatic Disease
9%
Confidence Interval
8%
N-glycan
8%
Image Interpretation
8%
Solid Tumors
8%
Tumor Metabolism
8%
Body Mass Index
8%
Patients with Prostate Cancer
8%